HU0203976A3 - Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them - Google Patents

Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HU0203976A3
HU0203976A3 HU0203976A HU0203976A HU0203976A3 HU 0203976 A3 HU0203976 A3 HU 0203976A3 HU 0203976 A HU0203976 A HU 0203976A HU 0203976 A HU0203976 A HU 0203976A HU 0203976 A3 HU0203976 A3 HU 0203976A3
Authority
HU
Hungary
Prior art keywords
adenozine
preparation
process
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU0203976A
Other versions
HU0203976D0 (en
HU0203976A2 (en
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Priority to HU0203976A priority Critical patent/HU0203976A3/en
Publication of HU0203976D0 publication Critical patent/HU0203976D0/en
Publication of HU0203976A2 publication Critical patent/HU0203976A2/en
Publication of HU0203976A3 publication Critical patent/HU0203976A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
HU0203976A 2002-11-15 2002-11-15 Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them HU0203976A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU0203976A HU0203976A3 (en) 2002-11-15 2002-11-15 Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (34)

Application Number Priority Date Filing Date Title
HU0203976A HU0203976A3 (en) 2002-11-15 2002-11-15 Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
NZ540029A NZ540029A (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine A3 receptor ligands
CNB2003801062293A CN1332960C (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine A3 receptor ligands
AT03773882T AT325123T (en) 2002-11-15 2003-11-11 Imidazoquinolines derivatives as adenosine receptor ligands a3
EA200500830A EA007595B1 (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine areceptor ligands
CA2505910A CA2505910C (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine a3 receptor ligands
PT03773882T PT1560828E (en) 2002-11-15 2003-11-11 imidazoquinoline derivatives as adenosine A3 receptor ligands
YUP-2005/0364A RS51320B (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine a3 receptor ligands
DE60305058T DE60305058T2 (en) 2002-11-15 2003-11-11 Imidazoquinolines derivatives as adenosine receptor ligands a3
ES03773882T ES2263039T3 (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as ligands a3 adenosine receptor.
AU2003282263A AU2003282263B2 (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine A3 receptor ligands
PCT/HU2003/000095 WO2004046146A1 (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine a3 receptor ligands
EP03773882A EP1560828B9 (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine a3 receptor ligands
PL376837A PL376837A1 (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine a3 receptor ligands
UAa200505875A UA78889C2 (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as an adenosine a3 receptor ligands
MXPA05005198A MXPA05005198A (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine a3 receptor ligands.
KR1020057008683A KR20050088291A (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine a3 receptor ligands
MEP-190/08A MEP19008A (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine a3 receptor ligands
DK03773882T DK1560828T3 (en) 2002-11-15 2003-11-11 Imidazoquinolinderivater as adenosine A 3 receptor ligands
JP2004552920A JP4533148B2 (en) 2002-11-15 2003-11-11 Imidazoquinoline derivatives as adenosine a3 receptor ligands
BR0316355-5A BR0316355A (en) 2002-11-15 2003-11-11 imidazoquinoline derivatives as adenosine A3 receptor ligands
ARP030104200A AR041968A1 (en) 2002-11-15 2003-11-14 Imidazole compounds as ligands derivatives of adenosine receptor
TW092131901A TWI248934B (en) 2002-11-15 2003-11-14 Compounds of adenosine A3 receptor ligands and the process for manufacturing the same
IL168516A IL168516A (en) 2002-11-15 2005-05-10 Imidazoquinoline derivatives as adenosine a3 receptor ligands
TNP2005000133A TNSN05133A1 (en) 2002-11-15 2005-05-10 Imidazoquinoline derivatives as adenosine a3 receptor ligands
ZA200503807A ZA200503807B (en) 2002-11-15 2005-05-11 Imidazoquinoline derivatives as adenosine A3 receptor ligands
US11/130,429 US7419977B2 (en) 2002-11-15 2005-05-16 Imidazoquinoline derivatives as adenosine A3 receptor ligands
IS7874A IS2456B (en) 2002-11-15 2005-05-31 Ímídasókínólínafleiður the adenosine A3 receptor
NO20052866A NO20052866D0 (en) 2002-11-15 2005-06-13 Imidazokinolinderivater as adenosine A3 receptor ligands
MA28334A MA27501A1 (en) 2002-11-15 2005-06-13 Imidazoquinoline derivatives as adenosine receptor ligands a3
CO05057645A CO5690577A2 (en) 2002-11-15 2005-06-14 Imidazoquinoline derivatives as adenosine receptor ligands a3
HR20050540A HRP20050540A2 (en) 2002-11-15 2005-06-14 Imidazoquinoline derivatives as adenosine a3 receptor ligands
HK05109885A HK1077819A1 (en) 2002-11-15 2005-11-07 Imidazoquinoline derivatives as adenosine a3 receptor ligands
US12/140,512 US7709489B2 (en) 2002-11-15 2008-06-17 Imidazoquinoline derivatives as adenosine A3 receptor ligands

Publications (3)

Publication Number Publication Date
HU0203976D0 HU0203976D0 (en) 2003-01-28
HU0203976A2 HU0203976A2 (en) 2004-07-28
HU0203976A3 true HU0203976A3 (en) 2004-08-30

Family

ID=10976564

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203976A HU0203976A3 (en) 2002-11-15 2002-11-15 Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them

Country Status (33)

Country Link
US (2) US7419977B2 (en)
EP (1) EP1560828B9 (en)
JP (1) JP4533148B2 (en)
KR (1) KR20050088291A (en)
CN (1) CN1332960C (en)
AR (1) AR041968A1 (en)
AT (1) AT325123T (en)
AU (1) AU2003282263B2 (en)
BR (1) BR0316355A (en)
CA (1) CA2505910C (en)
CO (1) CO5690577A2 (en)
DE (1) DE60305058T2 (en)
DK (1) DK1560828T3 (en)
EA (1) EA007595B1 (en)
ES (1) ES2263039T3 (en)
HK (1) HK1077819A1 (en)
HR (1) HRP20050540A2 (en)
HU (1) HU0203976A3 (en)
IL (1) IL168516A (en)
IS (1) IS2456B (en)
MA (1) MA27501A1 (en)
ME (1) MEP19008A (en)
MX (1) MXPA05005198A (en)
NO (1) NO20052866D0 (en)
NZ (1) NZ540029A (en)
PL (1) PL376837A1 (en)
PT (1) PT1560828E (en)
RS (1) RS51320B (en)
TN (1) TNSN05133A1 (en)
TW (1) TWI248934B (en)
UA (1) UA78889C2 (en)
WO (1) WO2004046146A1 (en)
ZA (1) ZA200503807B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU0105406A3 (en) * 2001-12-21 2003-12-29 Sanofi Aventis Imidazo[1,2-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HU0203976A3 (en) * 2002-11-15 2004-08-30 Sanofi Aventis Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
HU0400812A2 (en) * 2004-04-19 2006-02-28 Sanofi Aventis Crystalline forms of 2-amino-3-cyano-quinoline derivatives, process for their preparation and pharmaceutical compositions containing them
GT200600381A (en) 2005-08-25 2007-03-28 organic compounds
US20090088403A1 (en) * 2007-05-07 2009-04-02 Randy Blakely A3 adenosine receptors as targets for the modulation of central serotonergic signaling
HU0700395A2 (en) * 2007-06-07 2009-03-02 Sanofi Aventis Substituted [1,2,4] triazolo [1,5-a] quinolines, process for their preparation, pharmaceutical compositions thereof, and intermediates
US9199102B2 (en) 2009-07-21 2015-12-01 Oradin Pharmaceutical Ltd. A3 adenosine receptor ligands for modulation of pigmentation
JP6463276B2 (en) 2013-02-01 2019-01-30 ウェルスタット セラピューティクス コーポレイション Anti-inflammatory, antifungal, an amine compound having anti-parasitic and anti-cancer activity

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075343A (en) * 1976-09-13 1978-02-21 Pfizer Inc. Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof
GB1596652A (en) * 1977-01-20 1981-08-26 Roussel Lab Ltd Imidazo (1,2-a) quinoline-2-carboxylic acid and derivatives
FR2448541B1 (en) * 1979-02-09 1983-03-04 Roussel Uclaf
US4644002A (en) * 1979-02-09 1987-02-17 Roussel Uclaf Imidazo[2,1-C]quinolines, useful as antiallergic agents
SE441449B (en) * 1979-02-09 1985-10-07 Roussel Uclaf Heterocyclic derivatives and pharmaceutical compositions containing these derivatives spirit
AU4980999A (en) * 1998-07-10 2000-02-01 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The A3 adenosine receptor antagonists
US6448253B1 (en) * 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
CN1207298C (en) * 1999-09-28 2005-06-22 株式会社大塚制药工厂 Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents
US7160890B2 (en) * 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
NZ529966A (en) * 2001-05-31 2004-11-26 Sanofi Synthelabo Aminoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands
HU0105406A3 (en) * 2001-12-21 2003-12-29 Sanofi Aventis Imidazo[1,2-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HU0105407A3 (en) * 2001-12-21 2004-04-28 Sanofi Aventis Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HU0203976A3 (en) 2002-11-15 2004-08-30 Sanofi Aventis Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
MA27501A1 (en) 2005-08-01
HK1077819A1 (en) 2006-09-01
DE60305058D1 (en) 2006-06-08
AU2003282263B2 (en) 2009-05-14
PT1560828E (en) 2006-08-31
MXPA05005198A (en) 2005-08-18
WO2004046146A1 (en) 2004-06-03
PL376837A1 (en) 2006-01-09
ES2263039T3 (en) 2006-12-01
US7709489B2 (en) 2010-05-04
BR0316355A (en) 2005-09-27
TW200413369A (en) 2004-08-01
TWI248934B (en) 2006-02-11
AR041968A1 (en) 2005-06-01
CA2505910A1 (en) 2004-06-03
EP1560828B1 (en) 2006-05-03
ZA200503807B (en) 2006-08-30
JP2006515572A (en) 2006-06-01
RS20050364A (en) 2007-08-03
CO5690577A2 (en) 2006-10-31
HU0203976D0 (en) 2003-01-28
AT325123T (en) 2006-06-15
DE60305058T2 (en) 2006-12-14
NO20052866D0 (en) 2005-06-13
JP4533148B2 (en) 2010-09-01
IL168516A (en) 2011-05-31
CA2505910C (en) 2010-07-13
SI1560828T1 (en) 2006-08-31
DK1560828T3 (en) 2006-09-04
HRP20050540A2 (en) 2005-08-31
US20080255110A1 (en) 2008-10-16
AU2003282263A1 (en) 2004-06-15
UA78889C2 (en) 2007-04-25
CN1332960C (en) 2007-08-22
EA200500830A1 (en) 2005-10-27
IS7874A (en) 2005-05-31
KR20050088291A (en) 2005-09-05
RS51320B (en) 2010-12-31
CN1726213A (en) 2006-01-25
EP1560828A1 (en) 2005-08-10
TNSN05133A1 (en) 2007-05-14
US7419977B2 (en) 2008-09-02
MEP19008A (en) 2010-06-10
NO20052866L (en) 2005-06-13
HU0203976A2 (en) 2004-07-28
NZ540029A (en) 2007-01-26
US20050234056A1 (en) 2005-10-20
EP1560828B9 (en) 2007-03-28
EA007595B1 (en) 2006-12-29
IS2456B (en) 2008-11-15

Similar Documents

Publication Publication Date Title
TWI323256B (en) Novel benzazepine derivatives and pharmaceutical compositions comprising said compounds
HU0204229A3 (en) Compositions oral opioid formulations, compositions process for their preparation and their use
PL212943B1 (en) Crystalline O-desmethyl-venlafaxine succinate, the pharmaceutical composition, pharmaceutical dosage form, oral dosage form, application and process for the preparation of crystalline O-desmethyl-venlafaxine succinate
IL173973A (en) (naphthalenyl-methyl)-azetidinecarboxylic acid, derivatives thereof and pharmaceutical compositions containing it
HU0200076A3 (en) C-21 modified epothilones, process for their preparation, pharmaceutical compositions containing them
IL171214A (en) Carbonyl compounds, their preparation and pharmaceutical compositions comprising them
HU0300731A3 (en) Valsartan salts, process for their preparation and pharmaceutical compositions thereof
TWI326599B (en) Dihydrobenzodiazepin-2-one derivatives, pharmaceutical composition comprising the same, process for preparing the same, and use thereof
HU0202810A3 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands, process for their preparation and pharmaceutical compositions containing them
HU0302969A3 (en) Npyy5 antagonists, pharmaceutical compositions containing them and their use
HU0203294A3 (en) Benzodiazepine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HU0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
IL173079A (en) Ppar active compounds, pharmaceutical compositions comprising them and uses thereof for preparing medicaments
GB2389530B (en) Pharmaceutical compositions
IL165609A (en) Factor vii polypeptide conjugate, a method for its preparation and pharmaceutical compositions comprising it
AU2003302603A8 (en) Improved opioid pharmaceutical compositions
IL150883A (en) Pyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
HU0000748A3 (en) 4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
SK18762001A3 (en) Substituted benzimidazole, process for preparing them, their use and pharmaceutical compositions containing these compounds
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
HU0400784A3 (en) Bicyclic heterocondensated pyrrolcarboxamide derivatives, their use and pharmaceutical compositions containing them
SK14282002A3 (en) 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives, pharmaceutical composition containing the same, use thereof and method for their preparation
SK10212003A3 (en) Phenethanolamine derivatives, a process for their manufacture, pharmaceutical compositions containing them, their use and an intermediate
PT1427708E (en) Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
HU0200396A3 (en) Gluckokinase activators, process for their preparation, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished